Literature DB >> 8508531

Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.

D Fedida1, B Wible, Z Wang, B Fermini, F Faust, S Nattel, A M Brown.   

Abstract

In human myocardium, the nature of the K+ currents mediating repolarization of the action potential is still speculative. Delayed rectifier channels have recently been cloned from human myocardium, but it is unclear whether or not these currents are involved in the termination of the cardiac action potential plateau. In intact human atrial myocytes, we have identified a rapid delayed rectifier K+ current with properties and kinetics identical to those expressed by a K+ channel clone (fHK) isolated from human heart and stably incorporated into a human cell line for the first time. The myocyte current amplitude was 3.6 +/- 0.2 pA/pF (at +20 mV, n = 15) and activated with a time constant of 13.1 +/- 2 milliseconds at 0 mV (n = 15). The half-activation potential (V0.5) was -6 +/- 2.5 mV (n = 10) with a slope factor (k) of 8.6 +/- 2.2 (n = 10). The heterologously expressed fHK current amplitude was 136 pA/pF (at +20 mV, n = 9) with an activation time constant of 11.8 +/- 4.6 milliseconds at 0 mV; V0.5 was 4.1 +/- 2.4 mV (mean +/- SEM, n = 8); and k was 7.0. The conductance of single fHK channels was 16.9 picosiemens in 5 mM bath K+. Both native and cloned channel currents inactivated partially during sustained depolarizing pulses. Both currents were blocked by micromolar concentrations of 4-aminopyridine and were relatively insensitive to tetraethylammonium ions and class III antiarrhythmic agents.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508531     DOI: 10.1161/01.res.73.1.210

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  81 in total

1.  Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.

Authors:  Z Wang; X Zhang; D Fedida
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

Review 2.  Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium.

Authors:  J M Nerbonne
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Gating charge immobilization caused by the transition between inactivated states in the Kv1.5 channel.

Authors:  Z Wang; D Fedida
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

4.  Molecular correlates of the calcium-independent, depolarization-activated K+ currents in rat atrial myocytes.

Authors:  E Bou-Abboud; J M Nerbonne
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

Review 5.  Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.

Authors:  Sean T Duggan; Lesley J Scott
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

6.  Gating charge and ionic currents associated with quinidine block of human Kv1.5 delayed rectifier channels.

Authors:  D Fedida
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

7.  Effect of external pH on activation of the Kv1.5 potassium channel.

Authors:  Josef G Trapani; Stephen J Korn
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

8.  Kinetic analysis of the effects of H+ or Ni2+ on Kv1.5 current shows that both ions enhance slow inactivation and induce resting inactivation.

Authors:  Yen May Cheng; David Fedida; Steven J Kehl
Journal:  J Physiol       Date:  2010-06-25       Impact factor: 5.182

9.  Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Authors:  Ralph F Bosch; Alexander C Schneck; Saskia Csillag; Bernd Eigenberger; Uwe Gerlach; Joachim Brendel; Hans J Lang; Christian Mewis; Heinz Gögelein; Ludger Seipel; Volker Kühlkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-11       Impact factor: 3.000

Review 10.  Is there a future for antiarrhythmic drug therapy?

Authors:  P G Guerra; M Talajic; D Roy; M Dubuc; B Thibault; S Nattel
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.